WASHINGTON, DC 20549

                                 FORM 12b-25

                          NOTIFICATION OF LATE FILING

                                               Commission File Number 333-72097

(Check One):     [X] Form 10-K and Form 10-KSB   [ ] Form 11-K [ ]Form 20-F
                 [ ] Form 10-Q and Form 10-QSB   [ ] Form N-SAR

                 For Period Ended:
                 [  ]     Transition Report on Form 10-K and Form 10-KSB
                 [  ]     Transition Report on Form 20-F
                 [  ]     Transition Report on Form 11-K
                 [  ]     Transition Report on Form 10-Q and Form 10-QSB
                 [  ]     Transition Report on Form N-SAR
                 For the Transition Period Ended: Not Applicable

 Read Attached Instruction Sheet Before Preparing Form.  Please Print or Type.

   Nothing in this form shall be construed to imply that the Commission has
                  verified any information contained herein.

    If the notification relates to a portion of the filing checked above,
           identify the item(s) to which the notification relates:

                                Not Applicable.

                       PART I - REGISTRANT INFORMATION

Full name of registrant

(F/K/A American Communications Enterprises, Inc.)
Former name if applicable

1085 Business Lane, Suite 8
Address of principal executive office (STREET AND NUMBER)

Naples, Florida 34110
City, state and zip code


                        PART II - RULE 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following
should be completed.  (Check box if appropriate.)

 [X] (a)       The reasons described in reasonable detail in Part III of this
               form could not be eliminated without unreasonable effort or

 [X] (b)       The subject annual report, semi-annual report, transition report
               on Form 10-K, 10-KSB, 20-F, 11-K, or Form N-SAR, or portion
               thereof will be filed on or before the 15th calendar day
               following the prescribed due date; or the subject quarterly
               report or transition report on Form 10-Q, 10-QSB or portion
               thereof will be filed on or before the fifth calendar day
               following the prescribed due date; and

     (c)       The accountant's statement or other exhibit required by Rule
               12b-25(c) has been attached if applicable.

                             PART III - NARRATIVE

State below in reasonable detail the reasons why Form 10-K, 10-KSB, 11-K, 20-F,
10-Q, 10-QSB, N-SAR or the transition report portion thereof could not be filed
within the prescribed time period. (Attach Extra Sheets if Needed)

The Company has been unable to complete its Form 10-KSB on a timely basis due to
the delay in obtaining financial data and documentation necessary for the
completion of this report.

                         PART IV - OTHER INFORMATION

(1)      Name and telephone number of person to contact in regard to this

              Alfred G. Smith              305                 358-6300
         --------------------------     -----------        ------------------
                  (Name)                (Area Code)        (Telephone Number)

(2)      Have all other periodic reports required under Section 13 or 15(d) of
         the Securities Exchange Act of 1934 or Section 30 of the Investment
         Company Act of 1940 during the preceding 12 months or for such shorter
         period that the registrant was required to file such report(s) been
         filed?  If the answer is no, identify report(s).
                                                                 [X] Yes  [ ] No

(3)      Is it anticipated that any significant change in results of operations
         from the corresponding period for the last fiscal year will be
         reflected by the earnings statements to be included in the subject
         report or portion thereof?
                                                                 [ ] Yes  [X] No

         If so: attach an explanation of the anticipated change, both
         narratively and quantitatively, and, if appropriate, state the reasons
         why a reasonable estimate of the results cannot be made.

                               NEOGENOMICS, INC.
                  (Name of Registrant as Specified in Charter)

Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date MARCH 28, 2003                  By /s/ MICHAEL T. DENT, M.D.
    -----------------------------      ----------------------------------------
                                       Michael T. Dent, M.D.
                                       (President and Chief Executive Officer)

INSTRUCTION:  The form may be signed by an executive officer of the registrant
or by any other duly authorized representative.  The name and title of the
person signing the form shall be typed or printed beneath the signature.  If
the statement is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be filed
with the form.